Literature DB >> 27488498

The Status of Methicillin Resistance Among Egyptian Staphylococcus aureus Isolates: An Overview.

Alaa Abouelfetouh1.   

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) is responsible for a large number of antibiotic resistant infections worldwide. Understanding the epidemiology and identifying the molecular characteristics of MRSA is elemental in designing infection control plans to minimize the risks associated with these infections. The prevalence of MRSA varies between the different geographic regions. In Egypt, such knowledge is sparse, with a limited number of isolated studies reporting the infection rate of MRSA in select parts of the country. This work summarizes the few published reports that described MRSA prevalence and types in Egypt. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Epidemiology; MLST; MRSA; Methicillin; SCCmec; Staphylococcus

Mesh:

Substances:

Year:  2017        PMID: 27488498     DOI: 10.2174/1871526516666160802111200

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  3 in total

1.  Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.

Authors:  Wedad M Abdelraheem; Rasha M M Khairy; Alaa I Zaki; Shaimaa H Zaki
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-08-21       Impact factor: 3.944

2.  Whole-Genome Sequencing of Staphylococcus aureus and Staphylococcus haemolyticus Clinical Isolates from Egypt.

Authors:  Cesar Montelongo; Carine R Mores; Catherine Putonti; Alan J Wolfe; Alaa Abouelfetouh
Journal:  Microbiol Spectr       Date:  2022-06-21

3.  Investigation of Plasmids Among Clinical Staphylococcus aureus and Staphylococcus haemolyticus Isolates From Egypt.

Authors:  Carine R Mores; Cesar Montelongo; Catherine Putonti; Alan J Wolfe; Alaa Abouelfetouh
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.